---
title: "Denovo Sciences: Armenian AI platform using reinforcement learning to design small-molecule drug candidates."
url: https://emrr.uz/denovosciences
language: en
updated: 2026-11-20T03:46:51Z
source: emrr (https://emrr.uz)
---

# Denovo Sciences

Armenian AI platform using reinforcement learning to design small-molecule drug candidates.

[denovosciences.ai](https://denovosciences.ai/)

- **Industry**: AI / ML, Biotech
- **Based in**: Armenia

## Verified revenue: not connected yet

Is Denovo Sciences yours? Claim this page and connect Stripe, the App Store or Google Play: your MRR and growth show here, read straight from the source.

[Claim it if it’s yours](https://panel.emrr.uz/reserve/denovosciences)

## About

Denovo Sciences builds a reinforcement-learning platform that generates and screens candidate small molecules against protein or RNA targets for pharmaceutical clients, and plans to develop its own drug candidates. The company came out of the FAST ASCENT program in Armenia and was selected for EU4Innovation's VivaTech 2026 delegation. Co-founders are Hovakim Zakaryan (CEO), Mher Matevosyan (CTO) and Vardan Harutyunyan.

## Team

- **Hovakim Zakaryan**, Co-founder and CEO (Founder)
- **Mher Matevosyan**, Co-founder and CTO (Founder)
- **Vardan Harutyunyan**, Co-founder and CAIO (Founder)

## Audience

Followers on social networks

- [YouTube UCGygBfd6H1rD0mK7AcP7t_Q](https://www.youtube.com/channel/UCGygBfd6H1rD0mK7AcP7t_Q): ≈2,580 subscribers (Public count, read by emrr from YouTube (rounded), 20 November 2026)
- [Instagram @hellomyyoga](https://www.instagram.com/hellomyyoga/)
- [X @hellomyyoga](https://x.com/hellomyyoga)
- [Facebook hellomyyoga](https://www.facebook.com/hellomyyoga)
- [LinkedIn denovo-sciences](https://www.linkedin.com/company/denovo-sciences/)

Profile data from Stanbase.

Updated 20 November 2026

[This page in Markdown](https://emrr.uz/denovosciences.md)

[Get your verified page](https://emrr.uz/): Connect Stripe, the App Store or Google Play in two minutes and get a page like this one. emrr reads every figure itself, so investors don’t have to take your word for it. Free while MRR is under $1,000.
